Strides Shasun has signed definitive agreements with Vivimed Labs to set up two joint venture companies.
The 50:50 joint venture company (JVC) in India will own the USFDA approved formulation facility in Alathur, Chennai and the equal JVC in Singapore through Strides Pharma Global Pte, Singapore will own certain approved ANDAs and product pipeline.
Total volume of shares traded on the bourses today was higher by 221.44% to 648,839 compared with 22-day average volume of 201,854.
Shares of the company declined Rs 29.85, or 2.83%, to settle at Rs 1,025.90. The total volume of shares traded was 51,302 at the BSE (Thursday).